Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECLAIM-TNK: Intra-arterial Tenecteplase Bridging Therapy for Acute Ischemic Stroke
NCT07471282Phase 3Not yet recruiting
- Sponsor
- Chuansheng Zhao
- Start
- Mar 2026
- Primary completion
- Dec 2028
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Chuansheng Zhao. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07471282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07471282.